Xconomy National

Archives

by in

Entry	Author	Date	Location
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs	Luke Timmerman	12/12/11	Seattle
The Fall of Pfizer: How Big is Too Big for Pharma Innovation?	Luke Timmerman	08/29/11	National
Case Closed on Mirina vs. Marina, as Accelerator Startup Changes Name	Luke Timmerman	06/22/11	Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn?	Luke Timmerman	05/16/11	National
Regulus Names Chief Scientist	Luke Timmerman	04/18/11	San Diego
Regulus, UCSD Form Alliance	Luke Timmerman	04/14/11	San Diego
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News	Bruce V. Bigelow	03/31/11	San Diego
Regulus Gets License From NYU	Luke Timmerman	03/30/11	San Diego
AVI Biopharma Adds Chief Scientist	Luke Timmerman	03/28/11	Seattle
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry	Luke Timmerman	03/10/11	San Francisco
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up	Luke Timmerman	03/04/11	Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011	Luke Timmerman	02/07/11	San Diego
Some Prognostications on Biotechnology in 2011	Kleanthis Xanthopoulos	01/07/11	San Diego
Santaris Gets $14M From Pfizer	Luke Timmerman	01/04/11	San Diego
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase	Luke Timmerman	09/20/10	Seattle
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names	Luke Timmerman	08/16/10	Seattle
Accelerator, Taking a Break from Curing Cancer, Unwinds With Some Mini-Golf Hijinks	Luke Timmerman	07/12/10	Seattle
Febit Cuts 60 Percent of Staff	Ryan McBride	06/23/10	Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi	Luke Timmerman	06/22/10	San Diego
Leroy Hood’s Personalized Medicine Vision Enters Proving Ground at Ohio State	Luke Timmerman	05/18/10	Seattle
Bill Gates Backs Schrödinger, Bonanzle Lands Angel-VC Deal, Qliance Scores Big-Name Cash, & More Seattle-Area Deals News	Gregory T. Huang	05/04/10	Seattle
Mirina Nabs $3.9M	Luke Timmerman	04/29/10	Seattle
Accelerator’s Mirina Advances, Qliance Nabs Bezos Bucks, Spiration Adds $6.5M Debt, & More Seattle-Area Life Sciences News	Luke Timmerman	04/29/10	Seattle
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash	Luke Timmerman	04/26/10	Seattle
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo	Luke Timmerman	02/25/10	San Diego
Alnylam Maps Out First Steps in ‘RNA Decade’	Luke Timmerman	01/11/10	Boston
Regulus Adds IP from Baltimore Lab	Luke Timmerman	12/17/09	San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday	Luke Timmerman	12/09/09	San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology	Luke Timmerman	12/01/09	San Diego
Page 1 of 2	next page »